SUPN : Analysis & Opinions

  1. Supernus ADHD Drug Trial Shows Good Results (SUPN)

    October 12, 2016
    Supernus Pharmaceuticals said mid-stage trials of its ADHD drug, SPN-812, showed good results. The company plans to launch ...
  2. Smaller Biotechs Surging to New Highs

    August 23, 2016
    Small- and mid-cap biotechs are attracting healthy buying interest and setting off bullish divergences that support higher ...
  3. 3 Biotech Stocks Headed for New Highs (SCLN, SUPN)

    June 3, 2016
    These biotech leaders should continue to gain ground even if broad sector funds roll over and sell off.
Trading Center